Cancer Research CR  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 17, 71-75, January 1, 1957]
© 1957 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boutwell, R. K.
Right arrow Articles by Rusch, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boutwell, R. K.
Right arrow Articles by Rusch, H. P.

On the Role of Croton Oil in Tumor Formation*

R. K. Boutwell, Dorothy Bosch and H. P. Rusch

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison, Wis.)

The influence of small amounts of croton oil applied to the skin of mice for periods up to 83 weeks was tested. After a latent period of 8–10 weeks, papillomas appeared in the more susceptible strains, and usually by 20–24 weeks at least 50 per cent of the mice bore one or more tumors. Carcinomas appeared between 28 and 36 weeks, and the incidence was as high as 25 per cent of the effectual total4 by 1 year. Other strains of mice were tested and found to be less susceptible. The response to croton oil was much greater, and the latent period was shorter, when the mice had been previously treated with a subcarcinogenic amount of 9,10-dimethyl-1,2-benzanthracene.

* This work was supported in part by grants from the Alexander and Margaret Stewart Trust Fund and from the American Cancer Society on recommendation of the Committee on Growth of the National Research Council.

We are indebted to S. B. Penick and Co. for generous gifts of croton oil.

A preliminary report of a part of this work was presented at the Sixth International Cancer Congress, São Paulo, Brazil, July 23–29, 1954 (12).

4 Effectual total is defined as the number of mice alive at the time the first malignant tumor was detected.

Received 9/15/56.


This article has been cited by other articles:


Home page
Toxicol PatholHome page
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen
Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges
Toxicol Pathol, December 1, 2007; 35(7): 853 - 864.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1957 by the American Association for Cancer Research.